Nachrichten zur Amicus Therapeutics Inc. Aktie

Insiderhandel: Executive Chairman verkauft Aktien von Amicus Therapeutics im Wert von 121.866$

Crowley, John F. - Vorstand - Tag der Transaktion: 2022-11-15...…

XRP Prices Rally Over 15% As Markets Respond To Amicus Brief Approvals Involving SEC Case

XRP has risen in value lately as global markets respond to the latest developments surrounding the high-profile lawsuit involving the…

Amicus Therapeutics to Present at the Stifel 2022 Healthcare Conference

PHILADELPHIA, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amicus Therapeutics, Inc. - FOLD

NEW YORK, Nov. 14, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Amicus Therapeutics, Inc.…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amicus Therapeutics, Inc. - FOLD

New York, New York--(Newsfile Corp. - November 9, 2022) - Pomerantz LLP is investigating claims on behalf of investors of…

Amicus (FOLD) Q3 Earnings Beat, Galafold Sales Miss Estimates

Amicus Therapeutics (FOLD) posts a narrower-than-expected loss in the third quarter. FOLDs sole marketed drug Galafolds solid sales drive the…

Form 8-K AMICUS THERAPEUTICS, For: Nov 07

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amicus says no oral explanations in EU for lead program

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amicus Therapeutics Provides EU Regulatory Update for AT-GAA

PHILADELPHIA, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on…

Amicus Therapeutics (FOLD) Reports Q3 Loss, Misses Revenue Estimates

Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of 36.84% and 3.38%, respectively, for the quarter ended September 2022. Do…

Amicus Therapeutics reports mixed Q3 earnings; updates FY22 guidance

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-Q AMICUS THERAPEUTICS, For: Sep 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amicus Therapeutics Q3 2022 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: President & CEO verkauft Aktien von Amicus Therapeutics im Wert von 54.759$

Campbell, Bradley L. - Vorstand - Tag der Transaktion: 2022-11-01...…

Insiderhandel: Executive Chairman verkauft Aktien von Amicus Therapeutics im Wert von 117.052$

Crowley, John F. - Vorstand - Tag der Transaktion: 2022-11-01...…

Form 8-K AMICUS THERAPEUTICS, For: Oct 28

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

FDA extends review of Amicus muscle disorder therapy for second time

...(Reuters) - The U.S. Food and Drug Administration on Friday......…

Amicus shares fall 7% after FDA defers action on Pompe disease candidate application

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amicus Therapeutics Shares Fall 7.4% After Hours As FDA Delays Filing for AT-GAA Therapy

Amicus Therapeutics Shares Fall 7.4% After Hours As FDA Delays Filing for AT-GAA Therapy...…

Insiderhandel: Executive Chairman verkauft Aktien von Amicus Therapeutics im Wert von 114.148$

Crowley, John F. - Vorstand - Tag der Transaktion: 2022-10-17...…

The Onion mounts a defense of parody in Supreme Court amicus brief

The case before the court involves a man arrested after he spoofed the Parma, Ohio, police force in Facebook posts.…

Amicus Therapeutics Announces Participation at World Muscle Society 2022

PHILADELPHIA, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced four poster presentations highlighting its…

Insiderhandel: President & CEO verkauft Aktien von Amicus Therapeutics im Wert von 57.624$

Campbell, Bradley L. - Vorstand - Tag der Transaktion: 2022-10-03...…

Insiderhandel: Executive Chairman verkauft Aktien von Amicus Therapeutics im Wert von 121.926$

Crowley, John F. - Vorstand - Tag der Transaktion: 2022-10-03...…

The National Police Association Files Brief Amicus Curiae in the Case of Estate of McCartney v. Pierce County

INDIANAPOLIS, Sept. 26, 2022 /PRNewswire/ -- The National Police Association has filed a motion for leave to file a brief…

Cryptocurrency Lobby Group Submits “Friend of Court” Brief in XRP Lawsuit

An American advocacy group that promotes blockchain technology has submitted an amicus curiae brief in the SEC lawsuit against Ripple…

Amicus Therapeutics Announces Participation at the 2022 AANEM Annual Meeting

PHILADELPHIA, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced three poster presentations highlighting its…

Insiderhandel: Executive Chairman verkauft Aktien von Amicus Therapeutics im Wert von 111.628$

Crowley, John F. - Vorstand - Tag der Transaktion: 2022-09-15...…

THE NATIONAL COUNCIL FOR INCARCERATED AND FORMERLY INCARCERATED WOMEN AND GIRLS SUPPORTS SEX WORKERS IN THEIR FIGHT TO RESTORE THEIR FIRST AMENDMENT RIGHTS

WASHINGTON, Sept. 15, 2022 /PRNewswire/ -- The National Council filed an amicus brief today in Woodhull Freedom Foundation v. United…

Chamber of Digital Commerce to File Amicus Brief in Ripple v. SEC

Filing weighs in to help shape unsettled law in the absence of regulatory guidance WASHINGTON, Sept. 14, 2022 /PRNewswire/ --…

Schulte Roth & Zabel Files Supreme Court Amicus Brief in Discrimination Case

NEW YORK, Aug. 23, 2022 /PRNewswire/ -- On behalf of the Tanenbaum Center for Interreligious Understanding (Tanenbaum), a pro bono…

Insiderhandel: Executive Chairman verkauft Aktien von Amicus Therapeutics im Wert von 128.585$

Crowley, John F. - Vorstand - Tag der Transaktion: 2022-08-15...…

Insiderhandel: Chief People Officer verkauft Aktien von Amicus Therapeutics im Wert von 141.525$

Clark, David Michael - Vorstand - Tag der Transaktion: 2022-08-05...…

Insiderhandel: Chief Financial Officer verkauft Aktien von Amicus Therapeutics im Wert von 69.576$

Quimi, Daphne - Vorstand - Tag der Transaktion: 2022-08-05...…

Amicus (FOLD) Q2 Earnings Beat, Galafold Sales Miss Estimates

Amicus Therapeutics (FOLD) posts a narrower-than-expected loss for the second quarter. FOLDs sole marketed drug Galafolds solid sales drive the…

Council of the Great City Schools Files Amicus Brief in Higher Education Admissions Cases

WASHINGTON, Aug. 4, 2022 /PRNewswire/ -- On behalf of the Council of the Great City Schools (CGCS), a coalition of…

Amicus Therapeutics reports mixed Q2 earnings; reaffirms FY22 guidance

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K AMICUS THERAPEUTICS, For: Aug 04

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Executive Chairman verkauft Aktien von Amicus Therapeutics im Wert von 113.029$

Crowley, John F. - Vorstand - Tag der Transaktion: 2022-08-01...…

Insiderhandel: Chief Legal Officer verkauft Aktien von Amicus Therapeutics im Wert von 111.472$

Rosenberg, Ellen - Vorstand - Tag der Transaktion: 2022-08-01...…

Insiderhandel: President & CEO verkauft Aktien von Amicus Therapeutics im Wert von 54.883$

Campbell, Bradley L. - Vorstand - Tag der Transaktion: 2022-08-01...…

Amicus Therapeutics Q2 2022 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

California ChangeLawyers, Equal Justice Society, Wilson Sonsini File Amicus Brief in Support of College Admissions Policies That Foster Diversity

PALO ALTO, Calif., Aug. 1, 2022 /PRNewswire/ -- California ChangeLawyers, Equal Justice Society, and Wilson Sonsini Goodrich & Rosati, filed…